Related Experiment Video
Updated: Aug 17, 2026

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Platelet-activating factor (PAF) involvement in acetaminophen-induced liver toxicity and regeneration
A D Grypioti1, S E Theocharis, G K Papadimas
1Department of Experimental Pharmacology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, Goudi, GR 11527 Athens, Greece.
Abstract:
Acetaminophen-induced toxicity has been attributed to cytochrome P-450-generated metabolites, which covalently modify target proteins. However, the mechanism of liver injury pathogenesis needs to be further elucidated. Platelet-activating factor (PAF) is one of the mediators involved in inflammatory tissue alterations associated with acute liver failure. In this study, alterations in blood PAF levels and the serum activity of PAF-acetylhydrolase (PAF-AH) were investigated over the time course of liver injury and regeneration induced by acetaminophen treatment in rats. The administration of a toxic dose of acetaminophen (3.5 g/kg) in rats caused acute hepatic injury, as evident by alterations of biochemical (serum enzymes: ALT, AST and ALP) and liver histopathological (degree of inflammation and apoptosis) indices between 20 and 40 h post-treatment. The hepatic damage was followed by liver regeneration, made evident by three independent indices ([3H]thymidine incorporation into hepatic DNA, liver thymidine kinase activity and hepatocyte mitotic index), presenting a peak at 72 h. The PAF levels were elevated at 24 and 28 h, presenting a remarkable peak at 32 h post-treatment. PAF-AH activity presented different kinetics to that of PAF. The enzyme activity was relatively low at all time points examined before the rise in PAF activity, peaking later, at 72, 84 and 96 h. Our data demonstrate that PAF is involved in the pathogenesis of acute liver failure and in augmented compensatory liver tissue repair post-acetaminophen treatment. However, the putative role of PAF during liver toxicity and regeneration remains to be established.
Insights
Acetaminophen overdose causes liver injury and regeneration. This study shows platelet-activating factor (PAF) is involved in liver damage and repair, with PAF levels peaking during injury and PAF-acetylhydrolase activity during regeneration.
Area of Science:
- Hepatology
- Toxicology
- Inflammation
Background:
- Acetaminophen overdose is a leading cause of acute liver failure.
- Cytochrome P-450 metabolites are implicated in acetaminophen toxicity.
- Platelet-activating factor (PAF) is a mediator in inflammatory tissue responses.
Purpose of the Study:
- To investigate the role of PAF and PAF-acetylhydrolase (PAF-AH) in acetaminophen-induced liver injury and regeneration in rats.
- To analyze the temporal changes in blood PAF levels and PAF-AH activity during liver damage and repair.
Main Methods:
- Rats were administered a toxic dose of acetaminophen (3.5 g/kg).
- Biochemical markers (ALT, AST, ALP), histopathology, and liver regeneration indices ([3H]thymidine incorporation, thymidine kinase activity, mitotic index) were assessed.
- Blood PAF levels and serum PAF-AH activity were measured over time.
Main Results:
- Acetaminophen caused acute hepatic injury, indicated by elevated liver enzymes and histopathological changes between 20-40 hours.
- Liver regeneration peaked at 72 hours, confirmed by increased DNA synthesis and cell division.
- PAF levels peaked at 32 hours, while PAF-AH activity peaked later, around 72-96 hours.
Conclusions:
- PAF plays a role in the pathogenesis of acute liver failure induced by acetaminophen.
- PAF is also involved in the compensatory liver tissue repair following acetaminophen treatment.
- The precise role of PAF in liver toxicity and regeneration requires further investigation.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cirrhosis II: Pathophysiology
